| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1884 |
| Trial ID | NCT03497819 |
| Disease | Pancreatic Cancer |
| Altered gene | MESO|CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19/MESO CAR-T cells |
| Generation | 2nd |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | Autologous CARTmeso/19 Against Pancreatic Cancer |
| Year | 2017 |
| Country | China |
| Company sponsor | First Affiliated Hospital of Wenzhou Medical University |
| Other ID(s) | YXA-meso19 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||